SNY SCHEDULE 13G/A: SEC filing
Sanofi
Filed with the SEC on · accession 0001172661-26-004700
SNY filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 26, 2026. Sanofi filed an amended Schedule 13G indicating a passive institutional ownership position. The stock moved +0.5% by the first close after the filing.
Summary of the filing
Sanofi filed an amended Schedule 13G indicating a passive institutional ownership position. The filing text provided contains only EDGAR directory listing metadata and no substantive ownership details.
Key details
How SNY stock reacted
Close before
$41.60
Oct 23, 2026
First close after
+0.46%
$41.79
5 trading days
+6.59%
$44.34
Since filing
+8.97%
$45.33
✦ Ask GOAX AI about this filing — what it means for SNY, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SNY?
Click hereFrequently asked questions
What did SNY file with the SEC on Oct 26, 2026?
SNY filed a SCHEDULE 13G/A (SEC filing). Sanofi filed an amended Schedule 13G indicating a passive institutional ownership position. The filing text provided contains only EDGAR directory listing metadata and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did SNY stock react to this filing?
SNY closed at $41.60 before the filing and $41.79 on Oct 26, 2026 (+0.46%). Five trading days later: $44.34 (+6.59%).
Other SNY SEC filings
- 6-K · Guidance raiseOct 30, 2026
- 6-K · SEC filingOct 26, 2026
- 6-K · Material agreementOct 1, 2026
- 6-K · SEC filingSep 17, 2026
- 6-K · Fda approvalAug 6, 2026
- 6-K · Guidance raiseJul 30, 2026
- 6-K · SEC filingJul 30, 2026
- 6-K · Executive departureJul 27, 2026
- 6-K · Fda approvalJul 17, 2026
- 6-K · Fda approvalJul 7, 2026
Get alerts when SNY files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days